Sie sind auf Seite 1von 19

Fortis Healthcare Ltd.

Investor Presentation
Q3 – FY 2010
Safe Harbor
Except for the historical information contained herein, statements in this presentation and the subsequent discussions, which include words or phrases such as

“will”, “aim”, “will likely result”, “would”, “believe”, “may”, “expect”, “will continue”, “anticipate”, “estimate”, “intend”, “plan”, “contemplate”, “seek

to”, “future”, “objective”, “goal”, “likely”, “project”, “should”, “potential”, “will pursue” and similar expressions or variations of such expressions may

constitute "forward-looking statements". These forward-looking statements involve a number of risks, uncertainties and other factors that could cause actual

results to differ materially from those suggested by the forward-looking statements. These risks and uncertainties include, but are not limited to our ability to

successfully implement our strategy, our growth and expansion plans, obtain regulatory approvals, our provisioning policies, technological changes, investment

and business income, cash flow projections, our exposure to market risks as well as other risks. Fortis does not undertake any obligation to update forward-

looking statements to reflect events or circumstances after the date thereof.

“Fortis Healthcare Limited is proposing, subject to receipt of requisite approvals, market conditions and other considerations, a rights issue of its equity shares

with warrants and to file a Draft Letter of Offer with SEBI.” This presentation is not and should not be construed as an offer for sale within the United States of

any rights, warrants, equity shares or any other security of Fortis Healthcare Limited or as a solicitation of an offer to buy any of such rights, warrants, equity

shares or other securities. Securities of Fortis Healthcare Limited, including any offering of its rights, warrants, equity shares or any other security, may not be

offered, sold, resold or otherwise transferred within the United States absent registration under U.S securities laws or unless exempt from registration under such

laws. The offering of the securities of Fortis Healthcare Limited described in this advertisement has not been and will not be registered under U.S securities laws,

and accordingly, any offer or sale of these securities may be made only in a transaction exempt from registration.

2
Agenda

Highlights of the Quarter

Operating Parameters

Hospital Performances

Q&A

3
Highlights of the quarter

 The acquisition of 10 Wockhardt’s hospitals (including 2 hospitals in project stages), completed on


17th December.

 Ties up for management of 175 bedded MK Hospital – Bhiwani, Haryana

 13 hospitals in the network recorded all time high revenues

 Malar and Amritsar Hospital grew sequentially over the 8th quarter

 Fortis Escorts Delhi grew sequentially over the 6th quarter

 Noida, Vasant Kunj and Jaipur grew sequentially over the 4th quarter

 Launched a new clinic at Fortis La Femme dedicated towards foetal medicine

 Launched Cancer care clinic named “Cancure” at Vashi, in association with Dr. Suresh Advani

 Kicked-off cardiac surgery programme at Clinique Darne and also launched a comprehensive
mother and child care programme

 Construction completed for Oncology Block at Noida. Operations commence from ensuing quarter

4
Operating Highlights

 Financial Information:
 Network Operating Revenues: Q3 – Rs. 299 Cr. (+59%); 9M – Rs. 808 Cr. (+51%)

 Consolidated Operating Revenue: Q3 – Rs. 232 Cr. (+44%); 9M – Rs. 608 Cr. (+33%)

 Consolidated Operating EBITDA: Q3 – Rs. 35.6 Cr. (+43%); 9M – Rs. 93.5 Cr. (+56%)

 Net Profit for the quarter stood at Rs. 21.7 Cr., +330% over corresponding period

 EPS for the quarter grows from Re. 0.22 / share to Re. 0.88 / share

 Fortis Escorts Delhi achieved highest ever revenues of Rs. 70 Cr. for a quarter

 Fortis Escorts Delhi (+28%), Noida (+30%), Malar (+112%), Faridabad (+35%), Vasant Kunj (+44%), Jaipur
(+85%) and La Femme (+27%) also grew smartly

 Revenues from Cardiac, Ortho, Neuro, Renal Sciences, Oncology and Gastroenterology grew by 36%,
19%, 93%, 28%, 44% & 50% respectively

 Observed 98% increase in Neuro Surgery procedures over the corresponding quarter lead by Noida, Faridabad,
Jaipur, Vasant Kunj & Malar

5
Update on Wockhardt acquisition

 Business transfer completed effective w.e.f


17th Dec 2009

 Transition of ~3,200 employees and


consultants to Fortis

 IT platform integration completed Wockhardt Hospital, Kolkata*

 Senior management team strengthened in


the areas of finance and projects

 414 bedded Kolkata project and Mulund


hospital’s expansion work started

Wockhardt Hospital, Mulund, Mumbai

6
Brand Transition

7
Combined Business Presence – Pan India
Kamayani, Agra (2006)
Escorts, Amritsar (2006) Saraswati Heart Care, Allahabad (2006)
Sadbhavna Medical & Fortis Noida (2004)
Fortis Shalimar Bagh (2010) International Projects
Heart Institute, Patiala (2006)
Jessa Ram (2003) • Escorts-Amiri Diagnostic
Fortis Gurgaon Heart Center, Afghanistan (FY2006)
Fortis City Centre (2006)
La Femme (2005) • Mauritius (FY2009)

Fortis Mohali (2001) Vasant Kunj (2006)


Fortis MK Hospital, ISIC, Vasant Kunj (2006)
Bhiwani (2010) Yashoda Hospital, Ghaziabad (2006)
Kalyani, Gurgaon (2006) Escorts-Delhi (2006)
Escorts, Faridabad
GNRC, Guwahati (2009)
Ravindera Cath Lab, Hisar

Fortis Escorts Jaipur


(2006) Wockhardt – Sarat Bose Road, Kolkata (2009)
Wockhardt – Rashbehari Avenue, Kolkata (2009)
Goyal Hospital,
Wockhardt Hospital, (Anandpur) Kolkata (2009)
Jodhpur (2006)
Wockhardt, Mulund (2009) Escorts-Raipur (2006)
Wockhardt, Kalyan (2009) Birla Institute MRC, Gwalior (2006)
Fortis Modi Hospital, Kota (2006)
Fortis Wockhardt Total
SL Raheja (Mumbai) (2010)
HHPL (Mumbai) (2007) Particulars No. Capacity No. Capacity No. Capacity
Arneja Hospital,
Nagpur(2006) Greenfield 3 970 3 970
Fortis Malar (Chennai) 2008
Brownfield 6 1,147 8 1,368 14 2,515
Wockhardt, Nagarbhavi, Bengaluru (2009)
Managed 8 1,318 8 1,318
Wockhardt, Yashwant Pura, Bengaluru (2009)
Wockhardt, Cunningham Road, Bengaluru (2009) HCC’s/SC’s 13 72 13 72
Wockhardt, CH Road, Bengaluru (2009)
Wockhardt, BG Road, Bengaluru (2009) Projects 5 1,200 2 534 7 1,734
Fortis, RM Hospital, Bengaluru (2009) Total 35 4,707 10 1,902 45 6,609

8
No. of Procedures
Cardiac Ortho
+32% +28%
936
612
4,988
3,774 1045
676
1,560 2,095
1,529 505 463
1,288

CTVS & Pediatrics PTCA CAG Others Knee Replacements THR & Others

+98%
15,938 +109%
699

353 7,641

Neuro Dialysis

Q3 FY 09 Q3 FY 10
9
Performance Highlights

Consolidated: FHL and Subsidiaries

Network: FHL, Subsidiaries, Associates and O&M Hospitals

10
Snapshot – Financial Performance
Rs. in Cr.
+59%  Q3 FY 10 – Consolidated
Q3FY09 Q3FY10
299
 Operating Revenue - Rs. 232.5 Cr  44%
300  Operating EBITDA - Rs. 35.6 Cr  43%
+44%

232  Net Profit - Rs. 21.7 Cr  330%


250
 Q3FY10 - Network Revenue - Rs. 299.1 Cr.  59%
189
200 161
Statutory Q3FY09 Q3FY10
Occupancy 70% 74%
150
ARPOB (Annualized - Rs. Lakhs) 75 86

100 ALOS (Days) 3.9 3.7

 9M FY10 – Consolidated
50  Operating Revenue - Rs. 608.4 Cr.  33%
 Operating EBITDA - Rs. 93.5 Cr.  56%
0
 Net Profit - Rs. 42.3 Cr.  330%
Consolidated Network
 9M FY10 - Network Revenue - Rs. 808.2 Cr.  49%
Operating Revenues
11
Operating Revenue and PAT
Rs. in Cr.
Consecutive positive returns
250.0 25.0
232.5

21.7 Revenues
200.0 185.4 190.5 20.0 44%

172.6
161.1

150.0 15.0
13.0
PAT
100.0 10.0 330%

7.6
6.2
50.0 5.0
5.1

0.0 0.0
Q3FY09 Q4FY09 Q1FY10 Q2FY10 Q3FY10
Operating Revenues PAT
*PAT above is excluding exceptional items of gain of Rs. 6. 2 Cr. in Q2FY09 and our share of loss of Rs. 1.4 Cr in Malar hospital in Q4FY09

12
Summary – Consolidated Profit and Loss – Q3 FY10
Q3 FY10 Q3 FY09 Q-o-Q
Particulars % %
(Rs. Cr.) (Rs. Cr.) Growth
Operating Revenue 232.5 100.0% 161.1 100.0% 44.3%

Other Income # 8.7 3.7% 5.8 3.6% 50.8%

Total Income 241.2 166.8 44.6%

Direct Costs 64.3 27.7% 46.3 28.7% 39.0%

Employee Costs 48.2 20.7% 39.1 24.3% 23.3%

Other Costs 84.4 36.3% 50.8 31.6% 66.0%

EBITDA 44.3 19.0% 30.6 19.0% 44.5%

Finance Costs 6.9 3.0% 11.2 7.0% -38.8%

Depreciation & Amortization 13.8 5.9% 11.9 7.4% 16.2%

PAT 21.7 9.4% 5.1 3.1% 329.6%

EPS for the quarter (Rs.) 0.88 0.22


#Other income includes interest income and miscellaneous income

13
Summary – Consolidated Profit and Loss – 9MFY10
9MFY10 9MFY09
Particulars (%) (%) Growth (%)
(Rs. Cr.) (Rs. Cr.)
Operating Revenue 608.4 100.0% 457.9 100.0% 32.9%

Other Income # 15.4 2.5% 23.9 5.2% -35.7%

Total Income 623.8 481.9 29.5%

Direct Costs 171.9 28.2% 134.6 29.4% 27.7%

Employee Costs 132.7 21.8% 112.1 24.5% 18.4%

Other Costs 210.3 34.6% 151.6 33.1% 38.8%

EBITDA 108.9 17.9% 83.7 18.3% 30.1%

Finance Costs 25.0 4.1% 34.3 7.5% -27.0%

Depreciation & Amortization 36.9 6.1% 35.9 7.8% 2.8%

PAT* 42.3 6.9% 9.8 2.1% 330.2%

EPS for the period 1.70 0.71


#Other income includes interest income and miscellaneous income
* PAT is arrived after excluding exceptional items
14
Hospital Performances

15
Hospital wise Revenue & EBITDA
112% Rs. In Cr.
85%
44%
80 28%
35%
69.9
30%
70 27%
18%

60
54.5 3%

50
42.7
41.5
40
19%
18%

29.7
30 25.7
22.8
18.7
22%
28%

20 17.9 17.3 16.7


13.8 13.1
25%

11.1
27%

8.1 9
15%

5.8 7.3
13%

15%

10

20%

30%
18%
14%

28%
-6%

24%
13%

7%
0
Delhi Mohali Noida Vasant Kunj Faridabad Malar Jaipur Amritsar La Femme

Q3 FY09 Q3 FY10
16
Specialty Mix – 9MFY10

Renal, 4% Gastro, 2%

Onco, 2%
Neuro, 5%
MSH, 17%

OPD, 10%
Ortho, 8%

Other, 19%
Pulmo, 2%

Gynae, 3%

Cardiac, 43%
Others, 4%

Focus on key specialties Cardiac, Neuro, Ortho, Renal & Onco to continue…

17
Greenfield Hospitals : Planned

No. Location No. of Beds Area & Land Ownership Expected date of
commencement

1. Shalimar Bagh, NCR 350 7 Acres. Owned Q4’ 10

Owned
2. Kolkata, West Bengal 414 Q3’ 11
294,931 Sq ft

3. Gurgaon, NCR 450 11 Acres, Owned Q4’ 11

B. Lease
4. Peenya, Bengaluru 120 Q4’ 11
~70,000 Sq ft

5. Ludhiana – 2, Punjab 100 1,00,000 sq ft. B. Lease Q4’ 12

6. Ludhiana – 1, Punjab 200 1,55,000 sq. ft., B. Lease Q1’ 13

7. Ahmedabad, Gujarat 200 1,55,000 sq. ft., B. Lease Q2’ 13

Total 1,834

18
Thank You…

19